|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 31/505 | (2006.01) | ||
| A61K 31/513 | (2006.01) | ||
| A61K 31/675 | (2006.01) | ||
| A61P 31/18 | (2006.01) |
| (11) | Number of the document | 2640362 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11791161.0 |
| Date of filing the European patent application | 2011-11-18 | |
| (97) | Date of publication of the European application | 2013-09-25 |
| (45) | Date of publication and mention of the grant of the patent | 2014-09-10 |
| (46) | Date of publication of the claims translation | 2015-06-25 |
| (86) | Number | PCT/US2011/061515 |
| Date | 2011-11-18 |
| (87) | Number | WO 2012/068535 |
| Date | 2012-05-24 |
| (30) | Number | Date | Country code |
| 415600 P | 2010-11-19 | US |
| (72) |
OLIYAI, Reza, US
WISER, Lauren, US
MENNING, Mark, US
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
Janssen Sciences Ireland UC, Eastgate Village, Eastgate, Little Island, County Cork, IE |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Terapinės kompozicijos, apimančios rilpivirino hidrochloridą ir tenovofiro dizoproksilo fumaratą |
| THERAPEUTIC COMPOSITIONS COMPRISING RILPIVIRIN HCL AND TENOVOFIR DISOPROXIL FUMARATE |
| Payment date | Validity (years) | Amount | |
| 2022-11-10 | 12 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-11-18 |